EAU & ASCO: Penile Cancer 2023: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
See [https://pubmed.ncbi.nlm.nih.gov/36906413/ Original Guidelines] | '''See [https://pubmed.ncbi.nlm.nih.gov/36906413/ Original Guidelines]''' | ||
'''See [[Penile Cancer: Squamous Penile Cancer]] Chapter Notes''' | |||
== Background == | == Background == | ||
Line 593: | Line 595: | ||
** Localized disease: 81% | ** Localized disease: 81% | ||
** Distant metastasis: 18% | ** Distant metastasis: 18% | ||
=== Prognostic Factors === | |||
#'''<span style="color:#ff0000">Presence and extent of nodal metastases (most important)''' | |||
#*'''<span style="color:#ff0000">Extra-capsular extension in even one single LN carries a poor prognosis and is denoted as pN3''' | |||
#'''<span style="color:#ff0000">Depth of invasion''' | |||
#'''<span style="color:#ff0000">Grade in the primary tumour''' | |||
#'''<span style="color:#ff0000">Pathological subtype''' | |||
#'''<span style="color:#ff0000">Peri-neural invasion''' | |||
#'''<span style="color:#ff0000">Lymphovascular invasion''' | |||
== Follow-up == | == Follow-up == | ||
* Local or regional nodal recurrences usually occur within | === Recurrence === | ||
* | |||
* Follow-up also depends on the primary treatment modality | * Local or regional nodal recurrences usually occur within 2-3 years of primary treatment | ||
* | ** Local recurrence is easily detected by physical examination, by the patient himself or his physician. | ||
** Regional recurrence requires timely treatment by rILND with (neo)adjuvant chemotherapy/chemoradiotherapy. | |||
* | * Follow-up also depends on the primary treatment modality | ||
** Histology from the glans should be obtained to confirm disease-free status following laser ablation or topical chemotherapy | |||
* After local treatment with negative inguinal nodes | |||
** Follow-up should include physical examination of the penis and groins for local and/or regional recurrence. Additional imaging has no proven benefit | |||
=== Lymphedema === | |||
* Following nodal surgery, ideally, refer to specialist lymphoedema services for assessment and management before any significant lymphoedema occurs. | |||
** Specialist lymphoedema services offer a range of made-to-measure compression garments or multi-layer lymphoedema bandaging for lower limb and genital lymphoedema | ** Specialist lymphoedema services offer a range of made-to-measure compression garments or multi-layer lymphoedema bandaging for lower limb and genital lymphoedema | ||
*** For lower limb compression adjustable Velcro garments also exist. | * Assess for genital and lower limb lymphoedema at each outpatient clinic appointment | ||
* Advise good skin care, compression, exercise, massage, and elevation when resting as the mainstay of treatment. | |||
** For lower limb compression adjustable Velcro garments also exist. | |||
** Good skin care is critical to prevent infection that can damage remaining lymphatic channels. | |||
** Prophylactic antibiotics should be used following any episode of cellulitis | |||
*** Penicillin V, erythromycin or clindamycin recommended, except in genital lymphoedema where prophylactic trimethoprim can be used | |||
== References == | == References == | ||
Brouwer, Oscar R., et al. "European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update." ''European urology'' 83.6 (2023): 548-560. | Brouwer, Oscar R., et al. "European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update." ''European urology'' 83.6 (2023): 548-560. |